EDGAR Filing Documents for 0001493152-18-003095

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001493152-18-003095

Filing Date

2018-03-08

Accepted

2018-03-08 16:23:18

Documents

108

Period of Report

2017-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-k.htm	10-K	1716700
2		ex10-53.htm	EX-10.53	78594
3		ex10-54.htm	EX-10.54	77653
4		ex10-55.htm	EX-10.55	74644
5		ex21-1.htm	EX-21.1	6610
6		ex23-1.htm	EX-23.1	3857
7		ex31-1.htm	EX-31.1	17251
8		ex31-2.htm	EX-31.2	17731
9		ex32-1.htm	EX-32.1	8013
10		ex32-2.htm	EX-32.2	8001
	Complete submission text file	0001493152-18-003095.txt		7684904

Data Files

Seq	Description	Document	Type	Size
11	XBRL INSTANCE FILE	immy-20171231.xml	EX-101.INS	1047910
12	XBRL SCHEMA FILE	immy-20171231.xsd	EX-101.SCH	88218
13	XBRL CALCULATION FILE	immy-20171231_cal.xml	EX-101.CAL	118074
14	XBRL DEFINITION FILE	immy-20171231_def.xml	EX-101.DEF	343710
15	XBRL LABEL FILE	immy-20171231_lab.xml	EX-101.LAB	648447
16	XBRL PRESENTATION FILE	immy-20171231_pre.xml	EX-101.PRE	505887

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)